Deutsch English Français

Contact

EP1248835

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1248835

EP1248835 - GENETICALLY MODIFIED FIBROBLAST CELL [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 19.12.2008 Database last updated on 16.09.2024
Most recent event Tooltip	19.12.2008	Application deemed to be withdrawn	published on 21.01.2009 [2009/04]
Applicant(s)	For all designated states Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Im Neuenheimer Feld 280 69120 Heidelberg / DE
	[N/P]
Former [2002/42]	For all designated states Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Im Neuenheimer Feld 280 69120 Heidelberg / DE
Inventor(s)	01 / ANGEL, Peter Am Hang 7 69181 Leimen / DE
	02 / FUSENIG, Norbert Am Pferchelhang 32 69118 Heidelberg / DE
	03 / KOLBUS, Andrea Am Kehler Tor 3 76437 Rastatt / DE
	04 / SCHORPP-KISTNER, Marina Weidenweg 4 76448 Durmersheim / DE
	05 / SZABOWSKI, Axel Am Schlierbachhang 62 69118 Heidelberg / DE
	06 / MAAS-SZABOWSKI, Nicole Am Schliebachhang 62 69118 Heidelberg / DE
	07 / ANDRECHT, Sven Ortenauer Strasse 4 69126 Heidelberg / DE
	[2003/07]
Former [2002/42]	01 / ANGEL, Peter Schillerstrasse 18 76344 Eggenstein / DE
	02 / FUSENIG, Norbert Am Pferchelhang 32 69118 Heidelberg / DE
	03 / KOLBUS, Andrea Am Kehler Tor 3 76437 Rastatt / DE
	04 / SCHORPP-KISTNER, Marina Weidenweg 4 76448 Durmersheim / DE
	05 / SZABOWSKI, Axel Am Schlierbachhang 62 69118 Heidelberg / DE
	06 / MAAS-SZABOWSKI, Nicole Am Schliebachhang 62 69118 Heidelberg / DE
	07 / ANDRECHT, Sven Ortenauer Strasse 4 69126 Heidelberg / DE
Representative(s)	Schüssler, Andrea Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE
	[N/P]
Former [2002/42]	Schüssler, Andrea, Dr. Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE
Application number, filing date	01909465.5	12.01.2001
	[2002/42]
	WO2001DE00131
Priority number, date	DE2000111926	14.01.2000 Original published format: DE 10011926
	[2002/42]
Filing language	DE
Procedural language	DE
Publication	Type:	A2 Application without search report
	No.:	WO0151619
	Date:	19.07.2001
	Language:	DE
	[2001/29]
	Type:	A2 Application without search report
	No.:	EP1248835
	Date:	16.10.2002
	Language:	DE
	The application published by WIPO in one of the EPO official languages on 19.07.2001 takes the place of the publication of the European patent application.
	[2002/42]
Search report(s)	International search report - published on:	EP	14.02.2002
Classification	IPC:	C12N5/10, C12Q1/02, C12Q1/68, A61K39/395, A61K48/00, A61P17/00	[2008/16]
	CPC:	C12N5/0656 (EP,US); A61P17/00 (EP); A61P17/02 (EP); A61P17/06 (EP); A61P29/00 (EP); A61P35/00 (EP); (+) A61P43/00 (EP); A61K48/00 (EP,US); C12N2503/02 (EP,US); C12N2510/00 (EP,US); G01N2500/10 (EP,US) (-)
	Former IPC [2002/42]	C12N5/10, C12Q1/02, C12Q1/68, A61K39/395, A61K48/00, A61P17/00, // C12N15:63
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/42]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	GENETISCH VERÄNDERTE FIBROBLASTENZELLEN	[2002/42]
	English:	GENETICALLY MODIFIED FIBROBLAST CELL	[2002/42]
	French:	FIBROBLASTE GENETIQUEMENT MODIFIE	[2002/42]
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	06.08.2002	National basic fee paid
	06.08.2002	Designation fee(s) paid
	06.08.2002	Examination fee paid
Examination procedure	08.08.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	06.08.2002	Examination requested [2002/42]
	08.02.2005	Despatch of a communication from the examining division (Time limit: M06)
	17.08.2005	Reply to a communication from the examining division
	03.08.2006	Despatch of a communication from the examining division (Time limit: M06)
	31.01.2007	Reply to a communication from the examining division
	18.03.2008	Communication of intention to grant the patent
	29.07.2008	Application deemed to be withdrawn, date of legal effect [2009/04]
	03.09.2008	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2009/04]
Fees paid	Renewal fee
	29.01.2003	Renewal fee patent year 03
	30.01.2004	Renewal fee patent year 04
	28.01.2005	Renewal fee patent year 05
	31.01.2006	Renewal fee patent year 06
	31.07.2007	Renewal fee patent year 07
	Penalty fee
	Additional fee for renewal fee
	31.01.2007	07 M06 Fee paid on 31.07.2007
	31.01.2008	08 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[PX]EP1055366 (BOEHRINGER INGELHEIM INT [DE]) [PX] 1-4,6,10,15 * page 4, line 30 - line 47 *;
		[DA] - BOSSY-WETZEL ELLA ET AL, "Induction of apoptosis by the transcription factor c-Jun.", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, (1997), vol. 16, no. 7, ISSN 0261-4189, pages 1695 - 1709, XP002174993 [DA] 1-5,7 * the whole document * DOI: http://dx.doi.org/10.1093/emboj/16.7.1695
		[A] - SCHREIBER MARTIN ET AL, "Control of cell cycle progression by c-Jun is p53 dependent.", GENES & DEVELOPMENT, (19990301), vol. 13, no. 5, ISSN 0890-9369, pages 607 - 619, XP002174994 [A] 1-5,7 * the whole document *
		[AD] - SCHORPP-KISTNER M ET AL, "JunB is essential for mammalian placentation", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, (19990215), vol. 18, no. 4, ISSN 0261-4189, pages 934 - 948, XP002121786 [AD] 1-4,6,8,15,16 * the whole document * DOI: http://dx.doi.org/10.1093/emboj/18.4.934
		[A] - ORLANDINI MAURIZIO ET AL, "Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, 1996, (1996), vol. 93, no. 21, ISSN 0027-8424, pages 11675 - 11680, XP002174995 [A] 1,2,4,10 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.93.21.11675
		[A] - SUPERTI-FURGA G ET AL, "HORMONE-DEPENDENT TRANSCRIPTIONAL REGULATION AND CELLULAR TRANSFORMATION BY FOS-STEROID RECEPTOR FUSION PROTEINS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, 1991, (1991), vol. 88, no. 12, ISSN 0027-8424, pages 5114 - 5118, XP002174996 [A] 1,10 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.88.12.5114
		[DA] - STARK HANS-JUERGEN ET AL, "Organotypic keratinocyte cocultures in defined medium with regular epidermal morphogenesis and differentiation.", JOURNAL OF INVESTIGATIVE DERMATOLOGY, (199905), vol. 112, no. 5, ISSN 0022-202X, pages 681 - 691, XP002174997 [DA] 9-11 * the whole document * DOI: http://dx.doi.org/10.1046/j.1523-1747.1999.00573.x
		[T] - SZABOWSKI AXEL ET AL, "c-Jun and junB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin.", CELL, (20001122), vol. 103, no. 5, ISSN 0092-8674, pages 745 - 755, XP002174998 [T] 1-16 * the whole document * DOI: http://dx.doi.org/10.1016/S0092-8674(00)00178-1
		[T] - MAAS-SZABOWSKI NICOLE ET AL, "Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation.", JOURNAL OF INVESTIGATIVE DERMATOLOGY, (200105), vol. 116, no. 5, ISSN 0022-202X, pages 816 - 820, XP002174999 [T] 1-16 * the whole document * DOI: http://dx.doi.org/10.1046/j.1523-1747.2001.01349.x

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p